Singular Genomics Systems Inc (OMIC)
22.31
+8.85
(+65.75%)
USD |
NASDAQ |
Nov 04, 16:00
22.22
-0.09
(-0.40%)
After-Hours: 20:00
Singular Genomics Systems Enterprise Value: -71.17M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -71.17M |
| November 01, 2024 | -93.26M |
| October 31, 2024 | -93.61M |
| October 30, 2024 | -94.40M |
| October 29, 2024 | -92.96M |
| October 28, 2024 | -93.61M |
| October 25, 2024 | -91.91M |
| October 24, 2024 | -92.41M |
| October 23, 2024 | -93.81M |
| October 22, 2024 | -91.56M |
| October 21, 2024 | -89.16M |
| October 18, 2024 | -88.91M |
| October 17, 2024 | -88.76M |
| October 16, 2024 | -88.09M |
| October 15, 2024 | -89.81M |
| October 14, 2024 | -90.01M |
| October 11, 2024 | -91.24M |
| October 10, 2024 | -91.14M |
| October 09, 2024 | -89.04M |
| October 08, 2024 | -88.69M |
| October 07, 2024 | -89.09M |
| October 04, 2024 | -93.21M |
| October 03, 2024 | -89.41M |
| October 02, 2024 | -88.47M |
| October 01, 2024 | -88.47M |
| Date | Value |
|---|---|
| September 30, 2024 | -87.74M |
| September 27, 2024 | -88.19M |
| September 26, 2024 | -88.14M |
| September 25, 2024 | -87.52M |
| September 24, 2024 | -86.29M |
| September 23, 2024 | -86.02M |
| September 20, 2024 | -85.87M |
| September 19, 2024 | -86.37M |
| September 18, 2024 | -84.95M |
| September 17, 2024 | -86.52M |
| September 16, 2024 | -94.88M |
| September 13, 2024 | -95.95M |
| September 12, 2024 | -112.75M |
| September 11, 2024 | -112.71M |
| September 10, 2024 | -111.80M |
| September 09, 2024 | -111.85M |
| September 06, 2024 | -112.14M |
| September 05, 2024 | -111.43M |
| September 04, 2024 | -111.48M |
| September 03, 2024 | -111.19M |
| August 30, 2024 | -109.11M |
| August 29, 2024 | -109.15M |
| August 28, 2024 | -110.25M |
| August 27, 2024 | -109.05M |
| August 26, 2024 | -110.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-169.50M
Minimum
Sep 20 2023
2.212B
Maximum
Jun 01 2021
94.43M
Average
-94.28M
Median
Jun 17 2022
Enterprise Value Benchmarks
| Bruker Corp | 11.01B |
| Azenta Inc | 1.602B |
| Harvard Bioscience Inc | 134.55M |
| Bionano Genomics Inc | 24.70M |
| Akoya Biosciences Inc | 160.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.25M |
| Revenue (Quarterly) | 0.737M |
| Total Expenses (Quarterly) | 23.54M |
| EPS Diluted (Quarterly) | -8.57 |
| Gross Profit Margin (Quarterly) | -24.15% |
| Profit Margin (Quarterly) | -2.88K% |
| Earnings Yield | -167.5% |
| Normalized Earnings Yield | -167.50 |